Carlsmed to Go Public in $101 Million Bid to Scale 3D Printed Spine Implants
Carlsmed, a med-tech company based in Carlsbad, California, is set to go public, offering 6.7 million shares at $14 to $16 each, potentially raising $101 million. The company, founded in 2018, specializes in personalized spine surgery using 3D printed titanium implants created with AI technology. Carlsmed's innovative approach has shown promising results, with over 500 patients benefiting from custom implants and a low revision rate. The FDA has recognized Carlsmed's technology, granting it Breakthrough Device designation, which expedites market entry and signifies confidence in the product. The company's IPO aims to further expand its offerings and collect more clinical data to enhance patient outcomes in spine surgery.